Paulson & Co at a glance
Paulson & Co reported 9 positions worth $2.9 billion in its 13F-HR for Q3 2026, filed November 16, 2026. Its largest holdings were Madrigal Pharmaceuticals Inc (MDGL) at 25.8%, Perpetua Resources Corp (PPTA) at 23.9% and Acadian Asset Management Inc (AAMI) at 18.4%.
- Versus Q2 2026, it opened 2 new positions, added to 1, trimmed 0 and sold out of 1. Reported portfolio value went from $2.6 billion to $2.9 billion.
- The 10 largest positions made up 100.0% of the reported portfolio.
- Largest estimated buys in Q3 2026: Madrigal Pharmaceuticals Inc (MDGL) (added, about $76.4 million), Pvh Corporation (new position, about $46.0 million) and Warner Bros Discovery Inc (WBD) (new position, about $774,000).
Source: 13F-HR filings on SEC EDGAR.
- 13F portfolio · Q3 2026
- $2.9B
- +13.2% vs prior quarter
- Positions
- 9
- 2 new · 1 sold out
- Top 10 weight
- 100.0%
- Concentration of the 13F book
- Turnover
- 2%
- Quarter-over-quarter
Paulson & Co top 13F holdings, Q3 2026
Largest reported positions by market value, from the 13F-HR filed Nov 16, 2026
| # | Company | Weight | Value | Shares | vs Q2 2026 |
|---|---|---|---|---|---|
| 1 | Madrigal Pharmaceuticals IncMDGL | 25.77% | $751.7M | 1,491,619 | Added |
| 2 | Perpetua Resources CorpPPTA | 23.92% | $697.7M | 32,347,299 | Held |
| 3 | Acadian Asset Management IncAAMI | 18.37% | $535.9M | 5,843,282 | Held |
| 4 | Bausch Health Cos IncBHC | 14.64% | $427.1M | 73,255,869 | Held |
| 5 | International Tower Hill MinTHM | 9.14% | $266.4M | 104,486,703 | Held |
| 6 | Novagold Resources IncNG | 6.07% | $177.0M | 27,238,061 | Held |
| 7 | Pvh Corporation | 1.58% | $46.0M | 620,820 | New |
| 8 | Thryv Hldgs IncTHRY | 0.48% | $13.9M | 8,843,383 | Held |
| 9 | Warner Bros Discovery IncWBD | 0.03% | $774K | 25,000 | New |
Source: Paulson & Co 13F-HR on SEC EDGAR. Long equity positions only (put and call options excluded); weights are shares of the reported 13F portfolio, not total assets. How 13F filings work
Paulson & Co biggest buys and sells, Q3 2026
Largest estimated position changes versus Q2 2026
| Company | Move | Est. flow | Shares now | Weight now |
|---|---|---|---|---|
| Madrigal Pharmaceuticals IncMDGL | Added | +$76.4M | 1,491,619 | 25.77% |
| Pvh Corporation | New | +$46.0M | 620,820 | 1.58% |
| Alphabet IncGOOGL | Sold out | −$1.8M | 0 | - |
| Warner Bros Discovery IncWBD | New | +$774K | 25,000 | 0.03% |
Estimated flow = change in share count × quarter-end price (2 new, 1 added, 0 trimmed, 1 sold out). 13F reports show holdings on the last day of the quarter, not the trade dates.
SignalX for Paulson & Co
Don't miss the next Paulson & Co filing
- 13F alerts. A push when Paulson & Co files a new 13F or a 13D stake.
- Smart Money consensus. Which stocks Paulson & Co and other tracked funds bought together.
- Ask anything. An AI agent that reads every Paulson & Co filing and answers with sources.
Latest Paulson & Co SEC filings
Paulson & Co 13F holdings: frequently asked questions
What stocks does Paulson & Co own?
In its 13F-HR for Q3 2026 (filed November 16, 2026), Paulson & Co reported 9 positions worth $2.9 billion. The largest were Madrigal Pharmaceuticals Inc (MDGL), 25.8%; Perpetua Resources Corp (PPTA), 23.9%; Acadian Asset Management Inc (AAMI), 18.4%; Bausch Health Cos Inc (BHC), 14.6%; International Tower Hill Min (THM), 9.1%. The top 10 positions were 100.0% of the portfolio.
What did Paulson & Co buy in Q3 2026?
Compared with Q2 2026, Paulson & Co's largest estimated purchases were Madrigal Pharmaceuticals Inc (MDGL) (added, about $76.4 million), Pvh Corporation (new position, about $46.0 million) and Warner Bros Discovery Inc (WBD) (new position, about $774,000). In total it opened 2 new positions and added to 1. Amounts are estimated from share-count changes at quarter-end prices.
What did Paulson & Co sell in Q3 2026?
Compared with Q2 2026, Paulson & Co's largest estimated sales were Alphabet Inc (GOOGL) (sold out, about $1.8 million). In total it sold out of 1 positions and trimmed 0.
When does Paulson & Co file 13F reports?
Paulson & Co's latest 13F-HR was filed November 16, 2026 and covers the quarter ended September 30, 2026. 13F-HR reports are due within 45 days of each quarter-end, so the Q4 2026 report is due by February 14, 2027.
What is Paulson & Co's SEC CIK number?
Paulson & Co's SEC Central Index Key (CIK) is 1035674. EDGAR lists every Paulson & Co filing under that number.
Ask anything about Paulson & Co
The research agent reads Paulson & Co's filings, financials, insider trades and 13F holders, then answers with sources.